CNS Pharmaceuticals, Inc. — Form C-AR (Regulation Crowdfunding)
CNS Pharmaceuticals, Inc. of HOUSTON, TX filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2019-04-30.
Offering
- Filed: 2019-04-30
- Form: C-AR
- Accession: 0001683168-19-001250
Issuer
- CIK: 0001729427
- Website: www.cnspharma.com
- Legal status: Corporation
- Organized in: NV
- Incorporated: 2017-07-27
- Address: 2100 WEST LOOP SOUTH, HOUSTON, TX, 77027
- Employees: 4
Financials (as filed)
- Total assets (most recent): $683K
- Cash (most recent): $283K
- Net income (most recent): $-7.4M
- Net income (prior): $-219K
- Short-term debt: $1.2M
People (11)
| Name | Role | Location |
|---|
| Matthew Lourie | Chief Financial Officer | The Woodlands, TX |
| Christopher Downs | Chief Financial Officer | Las Vegas, NV |
| Donald H. Picker | Director | HOUSTON, TX |
| Jerzy (George) Gumulka | Director | HOUSTON, TX |
| John Climaco | Chief Executive Officer | HOUSTON, TX |
| John Climaco | Chief Executive Officer and Director | HOUSTON, TX |
| John Climaco | President, Chief Executive Officer and Director | HOUSTON, TX |
| Andrzej Andraczke | Director | HOUSTON, TX |
| Andrzej Andraczke | Directror | HOUSTON, TX |
| Jeffry Keyes | Director | Houston, TX |
| Carl Evans | Director | HOUSTON, TX |
Reg CF filing history (4)
More